Welcome to our dedicated page for Metropolitan Bank SEC filings (Ticker: MCB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Parsing a community bank’s credit tables and CECL footnotes can take hours. Metropolitan Bank’s disclosures are no exception: hundreds of pages detail loan concentrations across New York commercial real estate, shifts in deposit composition, and evolving net-interest margins. If you have ever wondered where the allowance build sits or when executives last bought shares, this SEC filings hub removes that frustration.
How it works: Our platform ingests every Metropolitan Bank insider trading Form 4 transactions notice, each Metropolitan Bank quarterly earnings report 10-Q filing, and every Metropolitan Bank 8-K material event within minutes of EDGAR release. AI-powered summaries translate banking jargon—tier 1 capital, liquidity ratios—into plain English, turning Metropolitan Bank SEC filings explained simply into a reality. Use real-time alerts for Metropolitan Bank Form 4 insider transactions real-time or drill into the Metropolitan Bank proxy statement executive compensation numbers without wading through PDFs.
Investors use these filings to track credit quality trends, compare quarter-over-quarter loan growth, or spot Metropolitan Bank executive stock transactions Form 4 ahead of dividend announcements. Need a deeper dive? Our AI highlights section-level changes so understanding Metropolitan Bank SEC documents with AI becomes effortless. Whether you’re scanning the Metropolitan Bank annual report 10-K simplified for segment breakouts or seeking Metropolitan Bank earnings report filing analysis on net-interest income, you’ll find every document, every update, and expert context in one place.
Terence J. Mitchell, a director of Metropolitan Bank Holding Corp. (MCB), reported a sale of common stock on 08/19/2025. The Form 4 shows 4,796 shares sold at a weighted average price of $72.4401, with prices in the transactions ranging from $72.1801 to $72.5800. After the sale, the reporting person beneficially owns 13,230 shares, which includes restricted stock units that vest 100% on January 27, 2026. The filing indicates the report was signed by an attorney-in-fact on 08/21/2025. All information is limited to the transactions and holdings disclosed on the Form 4.
Robert C. Patent, a director of Metropolitan Bank Holding Corp. (MCB), reported a sale of 5,000 shares of the issuer's common stock on 08/19/2025 at a weighted-average price of $72.7460 per share. After the reported transaction, the reporting person directly beneficially owns 103,685 shares.
The filing also shows indirect holdings of 32,882 shares via a sibling (over which the reporting person holds a power of attorney but disclaims beneficial ownership) and 14,445 shares held indirectly through a profit sharing plan. The report notes restricted stock units that vest 100% on January 27, 2026. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/21/2025.
The filing is a Form 144 notification for the proposed sale of 4,796 shares of common stock to be executed on or about 08/19/2025 on the NYSE. The filing lists an aggregate market value of $347,228.36 and reports 10,421,384 shares outstanding. The 4,796 shares were acquired through restricted stock vesting on three dates—12/31/2021 (1,296 shares), 02/01/2023 (1,000 shares) and 01/24/2025 (2,500 shares)—and were issued as fees for service as director. The broker listed for the sale is Osaic Wealth, Inc., with an address in Red Bank, NJ. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.
Form 144 notice from Metropolitan Bank Holding Corp. (MCB) reports a proposed sale of 5,000 common shares through J.P. Morgan Securities LLC with an aggregate market value of $363,700, scheduled approximately for 08/19/2025 on the NYSE. The filing shows those 5,000 shares equal the cumulative shares received as board compensation across multiple grant dates between 2017 and 2023. The issuer has 10,421,384 shares outstanding, and the filer reports no securities sold in the past three months. The signer also certifies they are not aware of any undisclosed material adverse information about the issuer.
Metropolitan Bank Holding Corp. (MCB) filed a Form 144 indicating an insider’s intention to sell up to 1,400 common shares through Fidelity Brokerage on the NYSE. Based on the filing’s stated market value of $111,020, the proposed transaction equals roughly 0.013 % of the company’s 10,660,109 shares outstanding, suggesting minimal market impact. The shares were originally acquired via open-market purchases—1,000 shares on 05/13/2022 and 400 shares on 03/13/2023—and are slated for sale on or after 07/22/2025. The filer reports no sales in the past three months and certifies awareness of no undisclosed adverse information. While quantitatively small, the notice provides transparency into insider activity and may be monitored by investors tracking sentiment.
FAQ
What is the current stock price of Metropolitan Bank (MCB)?
What is the market cap of Metropolitan Bank (MCB)?
